Emergency preparedness experts emphasize the need for medical countermeasures that can be easily distributed to civilian populations following a nuclear accident. This clinical necessity drove researchers at the Fralin Biomedical Research Institute at VTC to develop XOlacta, an experimental oral
The biological phenomenon of first-pass metabolism can completely neutralize a drug before it reaches systemic circulation, making early metabolic profiling a critical developmental milestone. Beyond this initial barrier, the intricate dance of absorption, distribution, metabolism, and
Pfizer’s torcetrapib serves as a stark reminder that hitting a specific biological target and improving biomarkers does not always translate into positive clinical outcomes for patients. This cautionary tale looms larger than ever in the current landscape, where the pharmaceutical industry finds
Establishing health sovereignty across Africa requires a shift from international import reliance toward a self-sustaining ecosystem anchored by regional manufacturing hubs. For decades, the continent remained vulnerable to global supply shocks, frequently finding itself at the end of the queue for
In the humid halls of the Louisiana State Capitol, a radical ideological shift is currently unfolding as the state’s top medical official attempts to rewrite the foundational principles of community wellness through a lens of absolute individual autonomy. The traditional pillars of public
The company's net debt jumped from NZD 14.5 million to NZD 38.6 million as it aggressively funded its expansion into South Africa and other global regions. Despite the rising debt levels, the 2026 fiscal year proved to be a landmark period for AFT Pharmaceuticals as it effectively balanced capital
